JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Update

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) saw a significant increase in short interest in the month of October. As of October 15th, there was short interest totaling 213,100 shares, an increase of 60.6% from the September 30th total of 132,700 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

JCR Pharmaceuticals Stock Performance

OTCMKTS JCRRF opened at $4.50 on Tuesday. JCR Pharmaceuticals has a one year low of $3.78 and a one year high of $5.00. The firm’s fifty day moving average is $4.49 and its two-hundred day moving average is $4.49.

JCR Pharmaceuticals Company Profile

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.